Javier Pemán, director general de Syral Iberia, en el programa Del Campo a la Mesa

Javier Pemán, director general de Syral Iberia, en el programa Del Campo a la Mesa

Audio no disponible. Inténtalo más tarde.
Preparando para la descarga

Preparando audio para descarga.

Escucha patrocinada. El audio empezará en pocos segundos...

X

Descripción de Javier Pemán, director general de Syral Iberia, en el programa Del Campo a la Mesa

maíz cereal Syral Ibérica

Comentarios

_('Imágen de usuario')

Descubre podcasts de otros países

The Collapsed Wavefunction

The Collapsed Wavefunction

The Collapsed Wavefunction is a podcast to talk about chemistry and demystify the scientific process. Hosted by Chad Jones, a PhD candidate studying Physical Chemistry, and Sam Matthews, a MSc candidate studying Organic Chemistry. New episodes every other week

Hematologic Oncology Update

Hematologic Oncology Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

JVIR: Journal of Vascular and Interventional Radio

JVIR: Journal of Vascular and Interventional Radio

The Journal of Vascular and Interventional Radiology (JVIR) delivers ongoing podcast discussions on topics in IR, such as interviews with authors of recent articles in the Journal and highlights of the Society of Interventional Radiology annual meeting. Each issues of JVIR covers critical and cutting-edge medical minimally invasive, clinical, basic research, radiological, pathological, and socioeconomic issues of importance to the field, and our free podcast series provides readers with additional insights into the articles found in the Journal.

happy

happy

tiny investigations into happiness and the good life.

Thyroid Cancer Update

Thyroid Cancer Update

Featuring one-on-one interviews with leading oncology investigators, this series bridges the gap between research and patient care by providing medical oncologists with access to the latest research developments and expert perspectives on differentiated and medullary thyroid cancer and the related clinical trial and treatment options.